extubation and liberation

Every additional day of mechanical ventilation independently increases mortality, VAP risk, and delirium. The SBT is one data point, not a binary gate — extubation readiness is a multifactorial assessment across airway, breathing, circulation, neurology, and anticipated trajectory. Post-extubation support (HFNC ± NIV) in high-risk patients significantly reduces reintubation.

ABCDE extubation assessment

A — airway

Can this patient protect and maintain their airway after the tube comes out?
Risk factors for post-extubation stridor: intubation >36 h, traumatic/repeated intubation, large ETT relative to airway, female sex, history of head/neck surgery or radiation
Cuff leak test — not routinely recommended (poor sensitivity/specificity). Consider in high-risk patients: deflate cuff → leak present if audible air escape or ≥10–15% drop in expired tidal volume. Absent leak ≠ mandatory failed extubation, but raises concern
If high stridor risk: methylprednisolone 20 mg IV q4h starting 12 h before planned extubation (4 doses total) — reduces post-extubation laryngeal oedema and reintubation
Have a plan for post-extubation stridor: nebulised epinephrine, heliox, and reintubation setup at bedside

B — breathing

Oxygenation: FiO2 ≤0.4 and PEEP ≤5–8 cmH2O (or tolerating these settings)
Ventilation: adequate minute ventilation without excessive WOB, PaCO2 stable or at patient’s baseline
Respiratory muscle strength: rapid shallow breathing index (RSBI = RR/VT) <105 breaths/min/L is the classic threshold, but sensitivity ~70% and specificity ~50% — a single number should not override clinical assessment
Negative inspiratory force (NIF): more negative than −20 to −25 cmH2O suggests adequate diaphragmatic strength
The SBT itself: 30 min on PS 5–8 cmH2O is sufficient — SOFTLY (JAMA 2019) showed PS trials had higher extubation success than T-piece. 2 h SBTs offer no added predictive value over 30 min

SBT failure ≠ “not ready” forever

Identify the reason: secretion load, fluid overload, anxiety, pain, deconditioning, diaphragm weakness, unresolved pathology. Address the cause and retry — don’t just add another day of ventilation reflexively.

C — circulation

Weaning-induced pulmonary oedema — transition from positive pressure → negative intrathoracic pressure increases venous return and LV afterload → flash oedema. Common in patients with LV dysfunction or fluid-positive balance
Clues during SBT: rising PCWP (if PAC in situ), new B-lines on lung ultrasound, tachycardia, hypertension, desaturation in the last 15 min of the trial
Management: diurese to euvolaemia before reattempting; some centres use prophylactic IV furosemide pre-SBT in at-risk patients
Stable haemodynamics on minimal/no vasopressors — low-dose norepinephrine (≤0.1 mcg/kg/min) is not an absolute contraindication but warrants careful assessment

D — disability (neurological readiness)

Consciousness: purposeful response to commands, sustained eye opening — no universal GCS threshold, but GCS ≥8T is commonly used
Cough strength: ask to cough on command → weak cough and heavy secretion burden predict reintubation better than most physiological indices
Secretion volume: needing suctioning more than q2h is a relative concern
Swallow assessment post-extubation in patients intubated >48 h, neurological injury, or head/neck pathology — aspiration risk is under-recognised

E — expected course

Planned return to OR within hours? Anticipated deterioration (e.g. evolving sepsis)? → defer extubation
Time of day matters — extubate when experienced staff are available, not at 3 am
Discuss ceiling of care: if reintubation would not be pursued, the threshold to extubate may be lower (compassionate extubation is a separate framework)

post-extubation respiratory support

Risk-stratify to guide support after tube removal.

risk category	criteria	recommended support
low risk	age <65, first intubation, no cardiac/respiratory comorbidity, simple SBT pass	HFNC (superior to conventional O2)
high risk	age ≥65, cardiac or chronic respiratory disease, intubated >7 days, failed prior SBT, obesity, multiple comorbidities	HFNC + prophylactic NIV (alternating)
hypercapnic	COPD, obesity hypoventilation, neuromuscular disease	NIV (bilevel) — strongest evidence for preventing reintubation

Maggiore (AJRCCM 2014) — HFNC vs Venturi mask post-extubation → fewer desaturations, lower reintubation rate with HFNC
Hernández (JAMA 2016) — HFNC vs conventional O2 in low-risk patients → ↓reintubation with HFNC (NNT ~20)
Hernández (JAMA 2016) — HFNC vs NIV in high-risk patients → HFNC non-inferior to NIV for reintubation prevention
Thille (JAMA 2019) — HFNC + prophylactic NIV vs HFNC alone in high-risk → ↓reintubation with combined strategy (12% vs 21%)

prophylactic vs rescue NIV

Prophylactic NIV post-extubation in high-risk patients reduces reintubation. Rescue NIV once post-extubation respiratory failure has developed delays reintubation without improving outcomes and may increase mortality — do not use NIV as a substitute for timely reintubation.

reintubation

Reintubation rate ~10–15% overall; >20% in high-risk populations
Reintubation within 48 h is associated with ↑mortality independent of illness severity — this reflects both the physiological insult and the tendency to delay reintubation
Clear criteria for calling it: persistent SpO2 <88% despite maximal support, progressive hypercapnia with acidosis, haemodynamic instability, inability to protect airway, worsening WOB

delayed reintubation

If a patient is failing post-extubation, reintubate early. Prolonged struggle on NIV/HFNC before inevitable reintubation worsens outcomes. The decision to reintubate should not require the same threshold as a cardiac arrest.

weaning categories

Per the ERS/ATS/ESICM classification:

category	definition	proportion
simple	passes first SBT and is extubated successfully	~70%
difficult	requires up to 3 SBTs or ≤7 days from first SBT	~15%
prolonged	>3 SBTs or >7 days from first SBT	~15%

Prolonged weaning → investigate: diaphragm dysfunction (ultrasound), cardiac causes (echo, BNP, fluid balance), critical illness polyneuropathy/myopathy, unresolved infection, metabolic (hypothyroid, malnutrition, electrolytes — phosphate, magnesium).

what NOT to do

Treating the SBT as pass/fail in isolation — integrate airway, neuro, cardiac, and trajectory assessment. Many “SBT failures” are treatable (fluid overload, pain, anxiety)
Waiting for a perfect cuff leak to extubate — absent cuff leak has a high false-positive rate; treat with steroids and reassess
Using rescue NIV to avoid reintubation once post-extubation respiratory failure is established — delays inevitable reintubation and worsens mortality
2 h T-piece SBTs as standard — 30 min PS trial is sufficient and better tolerated
Extubating without a post-extubation plan — decide HFNC vs NIV vs conventional O2 before pulling the tube
Ignoring fluid balance — a net-positive patient with borderline LV function will flash within minutes of losing positive pressure

extubation and liberation from mechanical ventilation